Underwood Capital Limited has released a press release.
Progress on MMJs Lucky Lake Facility MMPR Application
Filed with ASX ·
6ix hasn’t read this filing yet.
Underwood Capital Limited on 6ix
Earlier from Underwood Capital
- Satipharm Gelpell Outperforms Sativex in Phase 1 Trial
- Capital Raising
- Cannabis Legalisation Gives MMJ the Green Light
- Successful Results of Phase 1 Clinical Trial
- Extension of Yissum Licensing Agreement
Later from Underwood Capital
- MMJ Marks AUS Market Entry with Two Strategic Partnerships
- Health Canada Grants MMJ License to Produce Medical Cannabis
- Canada Takes Steps Towards Recreational Legalisation
- MMJ Enters Strategic Land Package Agreement
- MMJ to Commence Phase 2 Clinical Trial on Pediatric Epilepsy
Follow Underwood Capital into a list and get an email when it puts out news.
Follow Underwood Capital